Endocardial fibroplasia does not usually heal on its own. Endocardial fibroplasia, or endocardial elastosis, is a relatively common cardiac disease in infancy and childhood. It mainly manifests as heart failure, and patients may have symptoms such as shortness of breath, excessive sweating, feeding difficulties, and developmental delays, etc. If this disease is not treated actively, it may easily become life-threatening. This disease is mainly for the treatment of chronic cardiac insufficiency, can be under the guidance of the doctor intravenous digoxin, sildenafil or rapid digitalisations and other drugs to increase myocardial contractility to inhibit sympathetic nerves, angiotensin-converting enzyme inhibitors to improve the left ventricular remodeling, as well as furosemide, spironolactone and other diuretics, and the use of immunosuppressive drugs, such as prednisolone, when necessary, for treatment. Patients are advised to seek prompt medical attention and maintain long-term treatment under medical supervision.